Jane Street’s Biolase, Inc. BIOL Stock Holding History

Jane Street’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,109	Closed	-$1.92K	–	10424
2024 Q1	$1.92K	Buy	+10,109	New	+$4.93K	﹤0.01%	9065
2022 Q2	–	Sell	-12	Closed	-$10K	–	11212
2022 Q1	$10K	Buy	+12	New	+$11.1K	﹤0.01%	10075
2021 Q4	–	Sell	-16	Closed	-$26K	–	10973
2021 Q3	$26K	Buy	+16	New	+$26.1K	﹤0.01%	9716
2021 Q2	–	Sell	-5	Closed	-$11K	–	10583
2021 Q1	$11K	Buy	+5	New	+$12.3K	﹤0.01%	9016
2020 Q4	–	Sell	-21	Closed	-$15K	–	8269
2020 Q3	$15K	Sell	21 -22	-51%	-$20.6K	﹤0.01%	7047
2020 Q2	$50K	Buy	+43	New	+$49K	﹤0.01%	6868
2014 Q2	–	Sell	-2	Closed	-$74K	–	3241
2014 Q1	$74K	Buy	+2	New	+$69.8K	﹤0.01%	2553

Other funds holding BIOL

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jane Street's BIOL Position: Q2 2024 in Review

Jane Street sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 10,109 shares — an estimated $1.92K sold.

Jane Street first reported a position in BIOL in Q1 2014 and held it in 7 quarters. The position peaked at $74K in Q1 2014. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.

Jane Street reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
Jane Street sold 10,109 Biolase, Inc. shares in Q2 2024, an estimated $1.92K.
Jane Street first reported a position in Biolase, Inc. in Q1 2014 and held it in 7 quarters.
Jane Street's Biolase, Inc. position peaked at $74K in Q1 2014.
2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.